These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 10860819)
1. Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation. Ghosh-Choudhury N; Woodruff K; Qi W; Celeste A; Abboud SL; Ghosh Choudhury G Biochem Biophys Res Commun; 2000 Jun; 272(3):705-11. PubMed ID: 10860819 [TBL] [Abstract][Full Text] [Related]
2. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1). Franzén A ; Heldin NE Biochem Biophys Res Commun; 2001 Jul; 285(3):773-81. PubMed ID: 11453659 [TBL] [Abstract][Full Text] [Related]
3. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Yin F; Giuliano AE; Law RE; Van Herle AJ Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771 [TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells. Tomari K; Kumagai T; Shimizu T; Takeda K Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840 [TBL] [Abstract][Full Text] [Related]
5. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins. Zi X; Feyes DK; Agarwal R Clin Cancer Res; 1998 Apr; 4(4):1055-64. PubMed ID: 9563902 [TBL] [Abstract][Full Text] [Related]
6. BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. Wen XZ; Miyake S; Akiyama Y; Yuasa Y Biochem Biophys Res Commun; 2004 Mar; 316(1):100-6. PubMed ID: 15003517 [TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein signaling in prostate cancer cell lines. Brubaker KD; Corey E; Brown LG; Vessella RL J Cell Biochem; 2004 Jan; 91(1):151-60. PubMed ID: 14689587 [TBL] [Abstract][Full Text] [Related]
8. Indomethacin inhibits endothelial cell proliferation by suppressing cell cycle proteins and PRB phosphorylation: a key to its antiangiogenic action? Pai R; Szabo IL; Kawanaka H; Soreghan BA; Jones MK; Tarnawski AS Mol Cell Biol Res Commun; 2000 Aug; 4(2):111-6. PubMed ID: 11170841 [TBL] [Abstract][Full Text] [Related]
9. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Vaziri C; Stice L; Faller DV Cell Growth Differ; 1998 Jun; 9(6):465-74. PubMed ID: 9663465 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. Hu M; Wang J; Chen P; Reilly RM Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139 [TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Ghosh-Choudhury N; Ghosh-Choudhury G; Celeste A; Ghosh PM; Moyer M; Abboud SL; Kreisberg J Biochim Biophys Acta; 2000 Jul; 1497(2):186-96. PubMed ID: 10903423 [TBL] [Abstract][Full Text] [Related]
13. Dissociation of bone morphogenetic protein-mediated growth arrest and apoptosis of mouse B cells by HPV-16 E6/E7. Yamato K; Hashimoto S; Okahashi N; Ishisaki A; Nonaka K; Koseki T; Kizaki M; Ikeda Y; Nishihara T Exp Cell Res; 2000 May; 257(1):198-205. PubMed ID: 10854068 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor. Khwaja F; Djakiew D Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038 [TBL] [Abstract][Full Text] [Related]
15. BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1. Wong GA; Tang V; El-Sabeawy F; Weiss RH Am J Physiol Endocrinol Metab; 2003 May; 284(5):E972-9. PubMed ID: 12527559 [TBL] [Abstract][Full Text] [Related]
16. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity. Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019 [TBL] [Abstract][Full Text] [Related]
17. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node. Lodén M; Stighall M; Nielsen NH; Roos G; Emdin SO; Ostlund H; Landberg G Oncogene; 2002 Jul; 21(30):4680-90. PubMed ID: 12096344 [TBL] [Abstract][Full Text] [Related]
18. P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228. Sandor V; Senderowicz A; Mertins S; Sackett D; Sausville E; Blagosklonny MV; Bates SE Br J Cancer; 2000 Sep; 83(6):817-25. PubMed ID: 10952788 [TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333 [TBL] [Abstract][Full Text] [Related]
20. Sodium butyrate induces G2 arrest in the human breast cancer cells MDA-MB-231 and renders them competent for DNA rereplication. Lallemand F; Courilleau D; Buquet-Fagot C; Atfi A; Montagne MN; Mester J Exp Cell Res; 1999 Mar; 247(2):432-40. PubMed ID: 10066371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]